Rchr
J-GLOBAL ID:200901076859582910   Update date: Aug. 30, 2024

Nakai Yasuhiro

ナカイ ヤスヒロ | Nakai Yasuhiro
Affiliation and department:
Research field  (1): Medical equipment testing
Papers (23):
  • Akihito Tanaka, Kazuhiro Furuhashi, Kumiko Fujieda, Asuka Horinouchi, Kayaho Maeda, Shoji Saito, Tetsushi Mimura, Yosuke Saka, Tomohiko Naruse, Takuji Ishimoto, et al. Safety and Tolerability of ADR-001 Therapy for Immunoglobulin A Nephropathy. Kidney360. 2024
  • Takayuki Kitasaka, Shota Nakamura, Yuichiro Hayashi, Tsuyoshi Nakai, Yasuhiro Nakai, Kensaku Mori, Toyofumi Fengshi Chen-Yoshikawa. Development of panorama vision ring for thoracoscopy. International journal of computer assisted radiology and surgery. 2023. 18. 5. 945-952
  • Masaki Matsushita, Hiroshi Kitoh, Kenichi Mishima, Yasunari Kamiya, Daisaku Kato, Genta Takemoto, Kenta Sawamura, Shinji Ueno, Nakai Yasuhiro, Kazuki Nishida, et al. Phase 1b study on the repurposing of meclizine hydrochloride for children with achondroplasia. PloS one. 2023. 18. 7. e0283425
  • Akihito Tanaka, Kazuhiro Furuhashi, Kumiko Fujieda, Kayaho Maeda, Shoji Saito, Tetsushi Mimura, Yosuke Saka, Tomohiko Naruse, Takuji Ishimoto, Tomoki Kosugi, et al. Protocol for a Phase 1, Open-Label, Multiple-Center, Dose-Escalation Study to Evaluate the Safety and Tolerability of ADR-001 in the Treatment of Immunoglobulin A Nephropathy. Frontiers in medicine. 2022. 9. 883168-883168
  • Hiroshi Kitoh, Masaki Matsushita, Kenichi Mishima, Tadashi Nagata, Yasunari Kamiya, Kohei Ueda, Yachiyo Kuwatsuka, Hiroshi Morikawa, Yasuhiro Nakai, Naoki Ishiguro. Pharmacokinetics and safety after once and twice a day doses of meclizine hydrochloride administered to children with achondroplasia. PloS one. 2020. 15. 4. e0229639
more...
MISC (22):
Patents (2):
Education (2):
  • 2005 - 2008 Nagoya City University Graduate school of pharmaceutical sciences
  • 1981 - 1985 Kanazawa University Faculty of sciences Department of chemistry
Professional career (1):
  • 博士 (名古屋市立大学)
Work history (4):
  • 2019 - 2024/03 Nagoya University Hospital, Exploratory Oncology Research & Clinical Trial
  • 2007 - 2018 Taisho Pharmaceutical co.ltd. Development headquarter Deputy head
  • 1998 - 2007 Pfizer Global Research and Development Nagoya, PDM strategy Assosiate Director
  • 1985 - 1998 Mochida Pharmaceutical Fuji Central Research, Discovery DMPK Cheif
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page